文献速递炎症性肠病

含糖饮料、人工甜味饮料和天然果汁与炎症性肠病风险:121,490名参与者的队列研究

Sugar-sweetened beverages, artificially sweetened beverages and natural juices and risk of inflammatory bowel disease: a cohort study of 121,490 participants.
PubMed 文献 · Aliment Pharmacol Ther · 2022-07-18

该队列研究纳入英国生物银行121,490名基线无炎症性肠病的参与者,通过2009-2012年重复24小时膳食回顾获取饮料摄入,随访平均10.2年(标准差1.5)记录510例新发炎症性肠病。与不饮用者相比,每日饮用超过1单位含糖饮料者炎症性肠病风险显著升高(HR 1.51,95%CI 1.11-2.05),该关联在克罗恩病中显著(HR 2.05,95%CI 1.22-3.46),在溃疡性结肠炎中不显著(HR 1.31,95%CI 0.89-1.92);人工甜味饮料和天然果汁未见显著关联。

要点

  • 每日饮用超过1单位含糖饮料与炎症性肠病风险升高相关(HR 1.51,95%CI 1.11-2.05)。
  • 含糖饮料与克罗恩病风险显著相关(HR 2.05,95%CI 1.22-3.46),与溃疡性结肠炎不显著(HR 1.31,95%CI 0.89-1.92)。
  • 人工甜味饮料和天然果汁摄入与炎症性肠病风险未见显著关联。

核心结论

  • 研究提示含糖饮料摄入而非人工甜味饮料或天然果汁与炎症性肠病风险相关。

研究设计与样本

  • 队列研究纳入英国生物银行121,490名招募时无炎症性肠病的参与者。
  • 饮料摄入通过2009-2012年重复24小时膳食回顾获取。
  • 采用Cox比例风险模型估计风险比(HR)和95%置信区间(CI)。

主要发现

  • 平均随访10.2年(标准差1.5)期间记录510例新发炎症性肠病,其中克罗恩病143例、溃疡性结肠炎367例。
  • 与不饮用者相比,每日饮用超过1单位含糖饮料者炎症性肠病风险显著升高(HR 1.51,95%CI 1.11-2.05),但趋势检验不显著(p-trend=0.170)。
  • 含糖饮料与克罗恩病风险显著相关(HR 2.05,95%CI 1.22-3.46),与溃疡性结肠炎不显著(HR 1.31,95%CI 0.89-1.92)。
  • 人工甜味饮料或天然果汁摄入未见显著关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Inflammatory bowel diseases (IBD) have been related to high-sugar dietary patterns, but the associations of different types of beverages with IBD risk are largely unknown. AIMS: To examine any associations between intake of sugar-sweetened beverages, artificially sweetened beverages and natural juices and IBD risk METHODS: This cohort study included 121,490 participants in the UK Biobank who were free of IBD at recruitment. Intake of beverages was obtained from repeated 24-h diet recalls in 2009-2012. Cox proportional hazard models were used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) for associations of beverage intake with IBD risk. RESULTS: During a mean (standard deviation) follow-up of 10.2 (1.5) years, we documented 510 incident IBD cases, (143 Crohn's disease (CD) and 367 ulcerative colitis (UC)). Compared to non-consumers, participants consuming >1 unit per day of sugar-sweetened beverages were at significantly higher risk of IBD (HR 1.51, 95% CI 1.11-2.05), but the trend was non-significant (p-trend = 0.170). This association was significant for CD (HR 2.05, 95% CI 1.22-3.46), but not for UC (HR 1.31, 95% CI 0.89-1.92). We did not observe significant associations for the consumption of artificially sweetened beverages or natural juices. CONCLUSIONS: Our findings suggest an association between consumption of sugar-sweetened beverages, rather than artificially sweetened beverages or natural juices, and IBD risk.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Fu T, Chen H, Chen X, et al. Sugar-sweetened beverages, artificially sweetened beverages and natural juices and risk of inflammatory bowel disease: a cohort study of 121,490 participants. Aliment Pharmacol Ther. 2022. PMID: 35848057. doi:10.1111/apt.17149

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。